CACNA1A

Clinical trials for CACNA1A explained in plain language.

Never miss a new study

Get alerted when new CACNA1A trials appear

Sign up with your email to follow new studies for CACNA1A, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Hope for rare brain disease: Final-Stage trial tests promising pill

Disease control Not yet recruiting

This study is testing if a medication called N-Acetyl-L-Leucine can help control symptoms and improve daily life for people with rare, inherited disorders caused by a faulty CACNA1A gene. These disorders affect coordination, balance, and speech. In this final-stage trial, 60 part…

Matched conditions: CACNA1A

Phase: PHASE3 • Sponsor: IntraBio Inc • Aim: Disease control

Last updated Mar 27, 2026 12:40 UTC

CACNA1A

Get alerted when new CACNA1A trials appear

Hope for rare brain disease: Final-Stage trial tests promising pill